Credit Suisse’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-10,000
| Closed | -$192K | – | 3570 |
|
|
2021
Q4 | $192K | Hold |
10,000
| – | – | ﹤0.01% | 3452 |
|
|
2021
Q3 | $208K | Hold |
10,000
| – | – | ﹤0.01% | 3367 |
|
|
2021
Q2 | $10K | Buy |
+10,000
| New | +$10K | ﹤0.01% | 3561 |
|
|
2016
Q1 | – | Sell |
-52,108
| Closed | -$1.23M | – | 3775 |
|
|
2015
Q4 | $1.23M | Buy |
52,108
+271
| +0.5% | +$6.41K | ﹤0.01% | 2455 |
|
|
2015
Q3 | $1.17M | Buy |
51,837
+810
| +2% | +$18.2K | ﹤0.01% | 2513 |
|
|
2015
Q2 | $1.44M | Buy |
51,027
+934
| +2% | +$26.3K | ﹤0.01% | 2606 |
|
|
2015
Q1 | $1.38M | Sell |
50,093
-48,206
| -49% | -$1.33M | ﹤0.01% | 2479 |
|
|
2014
Q4 | $2.45M | Buy |
+98,299
| New | +$2.45M | ﹤0.01% | 2083 |
|
|
2014
Q3 | – | Sell |
-94,101
| Closed | -$1.95M | – | 4086 |
|
|
2014
Q2 | $1.95M | Buy |
94,101
+24,972
| +36% | +$518K | ﹤0.01% | 2377 |
|
|
2014
Q1 | $1.5M | Buy |
69,129
+1,294
| +2% | +$28.2K | ﹤0.01% | 2441 |
|
|
2013
Q4 | $1.39M | Buy |
67,835
+1,235
| +2% | +$25.3K | ﹤0.01% | 2619 |
|
|
2013
Q3 | $1.28M | Buy |
66,600
+23,130
| +53% | +$445K | ﹤0.01% | 2382 |
|
|
2013
Q2 | $777K | Buy |
+43,470
| New | +$777K | ﹤0.01% | 2623 |
|